aleena daniel  created a new article
50 w

Charting a Course: NTRK Fusion Gene Positive Tumors Market's US$230 Million Target in 2033 | # NTRK Fusion Gene Positive Tumors Market

Charting a Course: NTRK Fusion Gene Positive Tumors Market's US$230 Million Target in 2033

Charting a Course: NTRK Fusion Gene Positive Tumors Market's US$230 Million Target in 2033

NTRK (Neurotrophic Tyrosine Receptor Kinase) fusion genes result from genetic abnormalities where NTRK genes fuse with other genes, leading to uncontrolled cell growth.